The estimated Net Worth of Alison Cecily Finger is at least $407 mil dollars as of 5 January 2021. Ms. Finger owns over 1,854 units of Bluebird bio Inc stock worth over $14,560 and over the last 6 years she sold BLUE stock worth over $392,385. In addition, she makes $0 as Chief Commercial Officer at Bluebird bio Inc.
Alison has made over 13 trades of the Bluebird bio Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently she sold 1,854 units of BLUE stock worth $83,523 on 5 January 2021.
The largest trade she's ever made was selling 1,854 units of Bluebird bio Inc stock on 5 January 2021 worth over $83,523. On average, Alison trades about 294 units every 51 days since 2018. As of 5 January 2021 she still owns at least 25,103 units of Bluebird bio Inc stock.
You can see the complete history of Ms. Finger stock trades at the bottom of the page.
Alison C. Finger serves as Chief Commercial Officer of the Company. Ms. Finger has served as our Chief Commercial Officer since February 2018. Prior to this role, she served as our Senior Vice President, Marketing and Product Launch since August 2015. Prior to joining the Company, Ms. Finger served in roles with increasing responsibility at BMS, beginning her career in consumer medicines before progressing to global leadership roles where she was responsible for launching global, regional and national brands in hematology/oncology, neurodegenerative diseases, hepatitis, HIV/AIDS, diabetes, rheumatoid arthritis and migraine/pain. At BMS, she served as Vice President, Global Commercialization Virology from July 2004 to June 2007, Managing Director, Australia & New Zealand from July 2007 to May 2009, VP Global Commercialization, Alzheimer’s/Neuroscience from May 2009 to December 2012, and VP Global Commercialization, Hematology from December 2012 to May 2014. Ms. Finger received her B.A. in English Writing from St. Lawrence University and her M.B.A. from the Fuqua School of Business at Duke University.
Alison Finger is 56, she's been the Chief Commercial Officer of Bluebird bio Inc since 2018. There are 6 older and 15 younger executives at Bluebird bio Inc. The oldest executive at Bluebird bio Inc is Wendy Dixon, 64, who is the Independent Director.
Alison's mailing address filed with the SEC is C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446.
Over the last 11 years, insiders at Bluebird bio Inc have traded over $130,743,125 worth of Bluebird bio Inc stock and bought 6,469 units worth $399,874 . The most active insiders traders include Steven Gillis, John Maraganore y Robert I Tepper. On average, Bluebird bio Inc executives and independent directors trade stock every 8 days with the average trade being worth of $6,033. The most recent stock trade was executed by Thomas J Klima on 3 June 2024, trading 3,834 units of BLUE stock currently worth $3,719.
we are leading the gene therapy revolution. our integrated product platforms encompass gene therapy, cancer immunotherapy and gene editing – providing us with the potential to treat, and hopefully cure, a broad range of serious diseases. we have a lot of energy, and it’s not just the abundance of coffee that keeps us going. find out what sparks our excitement and inspires us every day.
Bluebird bio Inc executives and other stock owners filed with the SEC include: